All companies
Visit website
HyperSciences
OperatingHyperSciences, Inc.
Software & AI · Founded 2014
Harnessing the power of extreme velocity
Post-money valuation ⓘ
$104.4M
As of Sep 2022 · from HyperSciences Preferred Stock 2 · pre-money + amount raised, not a traded price
Total raised
$10,701,149
Across 3 rounds since 2018
Latest share price
$9.72
HyperSciences Preferred Stock 2 offering price
Financials
FY2017–FY2024 · from SEC filings · hover any figure for its source$0
−$1.5M
2017
$83K
−$2.2M
2018
$501K
−$5.7M
2019
$365K
$2.2M
2020
$2.0M
$2.0M
2021
$500K
−$1.9M
2022
$500K
−$1.9M
2023
$100K
−$1.6M
2024
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
Income statement
Revenue
$0
$82,860
$501,430
$365,000
$2,020,000
$500,000
$500,000
$100,000
Cost of goods sold
$0
$0
$0
$0
$0
$0
$0
$0
Gross margin
—
100%
100%
100%
100%
100%
100%
100%
Net income
-$1,492,072
-$2,166,043
-$5,680,777
$2,196,072
$2,019,458
-$1,921,788
-$1,921,788
-$1,599,742
Taxes paid
—
$0
$0
$0
$0
$0
$0
$0
Balance sheet
Cash
$290
$1,291,133
$1,431,036
$269,049
$222,237
$90,916
$90,916
$5,246
Accounts receivable
$0
$0
$120,000
$0
$0
$0
$0
$0
Total assets
$325,323
$2,071,164
$2,579,333
$1,445,232
$1,389,875
$1,242,270
$1,242,270
$1,032,992
Short-term debt
—
$1,607,175
$1,650,090
$1,721,285
$2,658,500
$2,245,105
$2,245,105
$2,419,127
Long-term debt
$564,114
$1,752,964
$1,935,893
$239,227
$0
$0
$0
$0
Total liabilities
$4,153,683
$3,360,139
$3,585,983
$1,960,512
$2,658,500
$2,245,105
$2,245,105
$2,419,127
Other
Headcount
1
—
7
15
19
—
8
7
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Post-money = pre-money + amount raised · caps marked$39.8M
post-money
$104.4M
post-money
HyperSciences Stock 2
HyperSciences Preferred Stock 2
A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
Fundraising history
Raised $432.8K / $3.9MInvestors 234Post-money $104.4M
Raised $1.1M / $1.1MInvestors 825Post-money $39.8M
HyperSciences Stock 1Closed
Reg CF annual-report compliance
Not required3+ reports filed & assets ≤ $10M
Filed 5 of 6 annual reports (FY2020–FY2025)
825 investors
holder-count proxy
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
View all 49 filings on EDGARSource: ManualCIK 0001646921Share price $9.72
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.